CTOs on the Move

HealthStrategiesGroup

www.healthstrategies.com

 
HealthStrategiesGroup is a Lambertville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

MBF Capital Corporation

MBF Capital Corporation is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Brijjitco

The Brijjit™ technology is created and produced by BrijjitCo, a limited liability company based in Atlanta, GA.. Our founder and CEO, Felmont (Monte) F. Eaves, III, MD, FACS, is a highly credentialed plastic surgeon who saw a gap and was determined to bridge it. No, we`re not a huge company. Yet. But we are singularly focused on improving the surgical landscape with breakthrough technologies that will support surgeons everywhere in their goal to deliver the most spectacular outcomes. We strongly believe that Brijjit™ is just such an innovation, and we don`t plan to stop there!

Medstar Surgical

Medstar Surgical is a College Point, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Sapling Co.

The Sapling Co. is a Huntingdon Valley, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Integrity Applications

Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea.